Rheumatoid Arthritis Terminated Phase 4 Trials for Etanercept (DB00005)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02109289Etanercept in Rheumatoid Arthritis and Vascular InflammationTreatment
NCT00796705Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)Treatment
NCT01783015Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus MethotrexateTreatment
NCT00706797Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA SubjectsTreatment